ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,754,892 | +5.7% | 136,212 | +0.7% | 3.97% | +20.2% |
| Q2 2023 | $12,067,671 | -16.8% | 135,212 | 0.0% | 3.30% | -24.1% |
| Q1 2023 | $14,497,431 | -8.8% | 135,212 | +3.8% | 4.35% | -2.9% |
| Q4 2022 | $15,902,792 | +13.5% | 130,212 | -4.1% | 4.48% | +18.8% |
| Q3 2022 | $14,014,000 | +8.3% | 135,712 | -2.5% | 3.77% | +6.9% |
| Q2 2022 | $12,941,000 | +260.2% | 139,212 | +354.8% | 3.53% | +276.8% |
| Q1 2022 | $3,593,000 | +142.8% | 30,612 | +178.3% | 0.94% | +151.6% |
| Q4 2021 | $1,480,000 | +57.6% | 11,000 | +54.1% | 0.37% | +89.8% |
| Q2 2021 | $939,000 | -68.6% | 7,137 | -69.3% | 0.20% | -72.4% |
| Q1 2021 | $2,995,000 | -22.7% | 23,237 | 0.0% | 0.71% | -38.3% |
| Q4 2020 | $3,875,000 | -14.1% | 23,237 | -20.5% | 1.15% | -21.4% |
| Q3 2020 | $4,512,000 | +114.2% | 29,237 | +105.4% | 1.47% | +141.3% |
| Q2 2020 | $2,106,000 | -44.6% | 14,237 | -57.8% | 0.61% | -61.6% |
| Q1 2020 | $3,799,000 | -2.8% | 33,737 | +20.1% | 1.58% | +18.1% |
| Q4 2019 | $3,909,000 | -32.9% | 28,100 | -53.5% | 1.34% | -38.7% |
| Q3 2019 | $5,825,000 | -14.8% | 60,480 | +1.9% | 2.19% | -14.7% |
| Q2 2019 | $6,838,000 | +30.9% | 59,380 | +33.8% | 2.57% | +14.0% |
| Q1 2019 | $5,224,000 | +8.0% | 44,380 | -42.5% | 2.25% | -6.3% |
| Q4 2018 | $4,839,000 | -11.6% | 77,242 | 0.0% | 2.41% | +7.1% |
| Q3 2018 | $5,473,000 | +11.6% | 77,242 | +4.7% | 2.25% | -2.2% |
| Q2 2018 | $4,906,000 | -5.3% | 73,745 | -6.9% | 2.30% | -8.9% |
| Q1 2018 | $5,183,000 | +3.8% | 79,245 | -36.4% | 2.52% | -6.2% |
| Q4 2017 | $4,993,000 | +90.7% | 124,639 | +72.6% | 2.69% | +65.4% |
| Q3 2017 | $2,618,000 | +183.9% | 72,226 | +117.5% | 1.63% | +147.1% |
| Q2 2017 | $922,000 | +80.8% | 33,214 | +82.4% | 0.66% | +52.7% |
| Q1 2017 | $510,000 | -52.5% | 18,214 | -65.6% | 0.43% | -54.3% |
| Q4 2016 | $1,073,000 | +73.6% | 53,000 | +72.4% | 0.94% | +119.3% |
| Q3 2016 | $618,000 | -12.6% | 30,750 | -42.2% | 0.43% | -23.2% |
| Q2 2016 | $707,000 | -28.4% | 53,241 | 0.0% | 0.56% | -34.3% |
| Q1 2016 | $988,000 | +1.3% | 53,241 | 0.0% | 0.85% | -2.0% |
| Q4 2015 | $975,000 | +3.5% | 53,241 | 0.0% | 0.87% | -7.1% |
| Q3 2015 | $942,000 | -43.0% | 53,241 | -43.1% | 0.94% | -33.2% |
| Q2 2015 | $1,654,000 | +1.9% | 93,541 | 0.0% | 1.40% | +12.3% |
| Q1 2015 | $1,623,000 | – | 93,541 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |